NCT00421096 2026-03-13
GEMCOL
Centre Oscar Lambret
Phase 2 Terminated
Clinical Trials
45 trialsNCT05521997 2026-03-13
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT03968406 2026-03-11
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04857528 2026-03-04
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Recruiting
NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06416696 2026-01-02
Toripalimab for High-risk Locally Advanced Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT03614949 2025-12-19
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT04567771 2025-11-14
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Mayo Clinic
Phase NA Recruiting
NCT07167069 2025-09-11
India HIV-CervCa Project
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT03277482 2025-05-31
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT06942416 2025-04-24
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT01566240 2024-12-05
INTERLACE
University College, London
Phase 3 Active not recruiting
NCT05051696 2024-06-04
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
Xi'an Jiaotong University
Phase 2 Active not recruiting
NCT01088347 2024-04-19
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
University Medical Center Groningen
Phase 1/2 Completed
NCT06128460 2023-11-30
Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.
Obstetrics & Gynecology Hospital of Fudan University
Phase 2 Not yet recruiting
NCT05588219 2023-11-24
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT03534713 2023-09-21
ONCOCOL01
University Hospital, Toulouse
Phase 3 Recruiting
NCT06039891 2023-09-15
Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Not yet recruiting
NCT05277688 2022-09-16
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Ruijin Hospital
Phase 3 Recruiting
NCT05310305 2022-04-11
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Unknown
NCT05310383 2022-04-11
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01991808 2019-11-26
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT04121975 2019-10-10
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00806117 2019-07-30
STARS
Sun Yat-sen University
Phase 3 Unknown
NCT03559803 2019-01-22
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
Sichuan University
Phase NA Unknown
NCT00287911 2017-12-02
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00428194 2017-11-29
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT03332069 2017-11-07
mEHT
University of Witwatersrand, South Africa
Phase 3 Unknown
NCT00600210 2017-08-23
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Leo W. Jenkins Cancer Center
Phase 2 Withdrawn
NCT03249519 2017-08-15
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting
NCT03175848 2017-07-21
Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01461772 2017-05-31
Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer
Asan Medical Center
Phase 3 Terminated
NCT00452920 2016-12-15
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
University of Miami
Phase 1/2 Withdrawn
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT01755845 2016-04-28
Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients
Wenzhou Medical University
Phase 3 Unknown
NCT01756170 2016-04-28
Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients
Wenzhou Medical University
Phase 3 Unknown
NCT01937650 2013-09-09
Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda
Makerere University
Phase 2/3 Completed
NCT00002949 2013-09-05
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
University of Chicago
Phase 1 Completed
NCT00137358 2013-01-24
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
University of Alabama at Birmingham
Phase 1 Withdrawn
NCT00118300 2011-07-08
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Case Comprehensive Cancer Center
Phase 1 Withdrawn
NCT01262144 2010-12-17
SUV Max as Predictor of Outcome in Cervical Cancer
Rambam Health Care Campus
Completed
NCT00005941 2010-04-02
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00165126 2009-11-02
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
Dana-Farber Cancer Institute
Completed
NCT00178269 2009-05-19
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
University of Rochester
Phase 2 Completed